| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
2 |
≤0.06 － 2 |
Ranbezolid (RBX 7644)  |
207 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
2 |
0.125 － 4 |
LBM415 (NVP-PDF-713, VIC-10495) |
207 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
2 |
0.125 － 64 |
Gentamicin (Gentamycin, Garamycin) |
178 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
2 |
≤0.25 － 2 |
Zosyn |
371 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
2 |
0.25 － 4 |
Ampicillin (Omnipen) |
1601 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
2 |
≤0.25 － 8 |
Zosyn |
475 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
2 |
0.5 － 2 |
Teicoplanin (Targocid) |
463 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
2 |
0.5 － 4 |
GSQ1530 |
1060 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
2 |
0.5 － 4 |
RWJ-416457 |
189 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
2 |
1 － 2 |
Daptomycin (Cubicin) |
16 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
2 |
1 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
1279 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
2 |
1 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
248 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
2 |
1 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
189 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
2 |
1 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
51 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
2 |
1 － 4 |
Vancomycin (Vancocyn, Lyphocin) |
311 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
2 |
? － ? |
Cefmenoxime |
1389 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
2 |
? － ? |
Cefotaxime (Cephotaxime, Claforan) |
1389 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
2 |
? － ? |
S-3578 |
1111 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
4 |
0.125 － 4 |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
248 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
4 |
0.25 － 4 |
Cefazolin (Ancef, Kefzol, Zolicef) |
248 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
4 |
0.25 － 8 |
Linezolid (PNU-100766, U-100766, Zyvox) |
1464 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
8 |
0.25 － 8 |
Amikacin (Amikin) |
248 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
16 |
≤0.25 － 16 |
Ampicillin (Omnipen) |
186 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
32 |
0.12 － 64 |
Tetracycline (Sumycin, Achromycin V, Steclin) |
396 |
| Staphylococcus aureus (methicillin-susceptible) |
>1 |
>64 |
0.25 － >64 |
Azithromycin (Zithromax, Sumamed, Zitrocin) |
120 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
64 |
0.5 － >64 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
178 |
| Staphylococcus aureus (methicillin-susceptible) |
≤1.7 |
≤1.7 |
≤1.7 － 109 |
Neomycin (Mycifradin, Neo-Fradin) |
604 |
| Staphylococcus aureus (methicillin-susceptible) |
2 |
2 |
0.25 － 4 |
Oritavancin (LY333328) |
72 |